A federal judge in New York this week denied a motion from Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard to dismiss an antitrust lawsuit filed by AngioDynamics (NSDQ:ANGO) alleging unfair competition, according to an Albany Business Review report. AngioDynamics filed the suit against Bard last May, claiming that the larger company illegally ties the sales of its […]
Hospitals sue BD, distributors, GPOs over alleged safety syringe monopoly
A group of healthcare providers levied a purported class action against BD, its distributors and group purchasing organizations accusing them of running a monopoly on the U.S. safety syringe market. The lawsuit, brought in the U.S. District Court for Southern Illinois, was filed on behalf of “healthcare providers nationwide” by a group of providers “who […]
AngioDynamics levels anti-trust suit against Bard over catheter tip locators
AngioDynamics (NSDQ:ANGO) said it leveled an anti-trust lawsuit against C.R. Bard (NYSE:BCR), alleging that the larger company illegally ties the sales of its peripherally inserted central catheters to its tip location devices. The lawsuit, filed today in the U.S. District Court for Northern New York, accuses Bard of maintaining its dominant position in the tip location market by only […]
Anti-trust regulators want more on Abbott’s pending, $25B St. Jude Medical buyout
Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ) said yesterday that U.S. anti-trust regulators want more information about their proposed $25 billion merger. The Federal Trade Commission’s requests mean that the waiting period on the deal is extended by 30 days “unless the period is extended voluntarily by the parties or terminated sooner by the FTC,” the […]
Becton Dickinson dodges hospital’s anti-trust suit
Becton Dickinson & Co. (NYSE:BDX) dodged an anti-trust lawsuit brought by a Georgia hospital system after a federal judge ruled last week that the plaintiff lacked standing in the putative class action. Southeast Georgia Health System sued BD last July, alleging that the Franklin Lakes, N.J.-based company monopolized the markets for hypodermic syringes and IV catheters. […]
Brazilian anti-trust regulator raids medical device companies
Brazil’s anti-trust regulator raided medical device companies and distributors as part of a probe into possible collusion in public bids for implantable devices, hospital networks and health plans. The country’s General Superintendence at the Administrative Council for Economic Defense, or CADE, said the Dec. 1 raids in 8 Brazilian counties in 4 states was to […]
Medtronic finally escapes Lenox MacLaren bone mill suit
A federal judge in Colorado dismissed an anti-trust lawsuit filed against Medtronic (NYSE:MDT) by bone mill maker Lenox MacLaren Surgical, ruling that Lenox failed to name the correct Medtronic subsidiary in the suit. Louisville, Colo.-based Lenox MacLaren 1st inked a distribution deal with Medtronic subsidiary Medtronic Sofamor Danek USA in 2000, hoping the pact would provide the scale to […]
Dentsply-Sirona union passes FTC muster
Dentsply International (NSDQ:XRAY) and Sirona Dental Systems (NSDQ:SIRO) said their proposed, $5.56 billion merger-of-equals cleared the U.S. Federal Trade Commission’s waiting period, clearing the way for a close in the 1st quarter of 2016. The merger, announced in September, would create the world’s largest dental equipment maker. It calls for Sirona shareholders to receive 1.8142 XRAY shares […]
Masimo settles beef with Mindray for $25m
UPDATED Nov. 20, 2015, with comment from Mindray. Masimo (NSDQ:MASI) said today that it agreed to settle its legal beef with Mindray (NYSE:MR) for $25 million. The settlement ends a bevy of legal proceedings in the U.S. and China, where Mindray is based. Masimo 1st sued Mindray in December 2012 in a California federal court, alleging patent infringement and breach […]
Steris, Synergy delay shareholder votes ahead of anti-trust ruling on $2B merger
Steris (NYSE:STE) and Synergy Health postponed their shareholders meetings to give a U.S. court time to rule on the Federal Trade Commission’s bid to halt their $1.9 billion merger. Mentor, Ohio-based Steris said it moved its meeting from Sept. 24 to Oct. 2; Synergy plans to hold its vote the same day, according to a regulatory filing. Earlier […]
FTC: We might force M&A divestitures in outside markets
The U.S. Federal Trade Commission last week said it may force companies to divest assets outside of the market the anti-monopoly bureau its trying to regulate.
MassDevice Network
@MassDevice
LinkedIn
Google+